Interestingly, gene pathways that were upregulated by MENIN/DOT1L inhibitors include a pathway for negative cell proliferation (Supplementary Figure S5H), which may contribute to their potent inhibition of MLLr leukemia. This evidence concerns the gene MEN1 and leukemia.